Researchers at DSMZ Develop Innovative Software for Biolog Inc. Phenotypic Analyses to Improve Our Understanding of the Metabolic Processes of Microorganisms and Other Cells
4/27/2012 9:30:56 AM
More...
|
Biolog Inc. Announces Appointment of Distributors in Europe
3/29/2012 9:19:45 AM
More...
|
Biolog, Inc. Release: Anti-Cancer Drug Sensitivity Changes Detected With Biolog Phenotype MicroArrays
4/8/2011 8:58:31 AM
More...
|
Biolog, Inc. Launches MicroStation(TM) Version of Its Revolutionary GEN III Microbial Identification System
3/11/2009 9:13:12 AM
More...
|
Biolog, Inc. Announces Successes in Analysis and Identification of Mycobacterium, Nocardia, and other Pathogenic Bacteria
11/14/2008 9:17:16 AM
More...
|
Biolog, Inc. Initiates Launch of Its Revolutionary GEN III Microbial Identification System
11/30/2007 11:50:44 AM
More...
|
Biolog, Inc. and HSC-Rangel College of Pharmacy Receive $1 Million National Institutes of Health (NIH) Phase II STTR Grant to Develop Phenotype MicroArray™ Capabilities for Bacterial Pathogens
10/10/2007 10:09:18 AM
More...
|
Biolog, Inc. Announces Additional Phenotype MicroArray(TM) Capabilities for Mammalian Cells
9/27/2007 8:30:17 AM
More...
|
Biolog, Inc. Announces New OmniLog(R) Combo System
12/18/2006 12:41:47 PM
More...
|
Biolog, Inc. Awarded National Institutes of Health (NIH) Grant To Develop Antimicrobial Database Using Phenotype MicroArray Technology Platform
10/19/2005 5:12:52 PM
More...
|
|